Cervical Carcinoma: Oncobiology and Biomarkers

Int J Mol Sci. 2021 Nov 22;22(22):12571. doi: 10.3390/ijms222212571.

Abstract

Cervical cancer is one of the most common types of carcinomas causing morbidity and mortality in women in all countries of the world. At the moment, the oncology, oncobiology, and oncomorphology of cervical cancer are characterized by the accumulation of new information; various molecular biological, genetic, and immunohistochemical methods of investigation of the mechanisms of cervical carcinogenesis are tested and applied; targeted antitumour drugs and diagnostic, prognostic, and predictive biomarkers are being searched for. Many issues of the etiopathogenesis of cervical cancer have not been sufficiently studied, and the role of many biomarkers characterizing various stages of cervical carcinogenesis remains unclear. Therefore, the target of this review is to systematize and understand several problems in the pathogenesis of cervical cancer and to evaluate the significance and role of biomarkers in cervical carcinogenesis.

Keywords: biomarkers; carcinoma of the cervix; cervical carcinogenesis; immunohistochemistry.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Carcinogenesis / genetics*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / therapy
  • Cervix Uteri / pathology
  • Female
  • Humans
  • Uterine Cervical Neoplasms / diagnosis
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / therapy

Substances

  • Biomarkers, Tumor